Atlas Trials

A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery

Clinical trial NCT06680466 · COMPLETED

Trial details

NCT number
NCT06680466
Sponsor
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pain
Start date
2023-12-26
Primary completion
2024-07-15
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.